ClearPoint Neuro, Inc. (CLPT)
USD 11.31
(-6.8%)
USD 11.31
(-6.8%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 23.95 Million USD | 16.56% |
| 2022 | 20.55 Million USD | 26.09% |
| 2021 | 16.29 Million USD | 27.05% |
| 2020 | 12.82 Million USD | 14.37% |
| 2019 | 11.21 Million USD | 52.54% |
| 2018 | 7.35 Million USD | -0.36% |
| 2017 | 7.37 Million USD | 28.35% |
| 2016 | 5.74 Million USD | 25.15% |
| 2015 | 4.59 Million USD | 27.46% |
| 2014 | 3.6 Million USD | -8.3% |
| 2013 | 3.93 Million USD | -22.29% |
| 2012 | 5.05 Million USD | 32.48% |
| 2011 | 3.81 Million USD | 43.03% |
| 2010 | 2.66 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 7.85 Million USD | 2.87% |
| 2024 Q1 | 7.63 Million USD | 12.17% |
| 2023 Q4 | 6.81 Million USD | 18.19% |
| 2023 Q1 | 5.43 Million USD | 5.01% |
| 2023 Q3 | 5.76 Million USD | -3.16% |
| 2023 Q2 | 5.95 Million USD | 9.52% |
| 2023 FY | 23.95 Million USD | 16.56% |
| 2022 Q3 | 5.14 Million USD | -1.04% |
| 2022 Q4 | 5.17 Million USD | 0.54% |
| 2022 Q1 | 5.03 Million USD | 17.49% |
| 2022 Q2 | 5.2 Million USD | 3.36% |
| 2022 FY | 20.55 Million USD | 26.09% |
| 2021 Q2 | 3.41 Million USD | -15.31% |
| 2021 FY | 16.29 Million USD | 27.05% |
| 2021 Q4 | 4.28 Million USD | -6.38% |
| 2021 Q1 | 4.03 Million USD | 8.45% |
| 2021 Q3 | 4.57 Million USD | 34.02% |
| 2020 Q2 | 2.47 Million USD | -20.47% |
| 2020 Q1 | 3.11 Million USD | -2.96% |
| 2020 Q4 | 3.71 Million USD | 5.59% |
| 2020 Q3 | 3.51 Million USD | 42.03% |
| 2020 FY | 12.82 Million USD | 14.37% |
| 2019 Q3 | 2.92 Million USD | 12.32% |
| 2019 Q4 | 3.21 Million USD | 9.67% |
| 2019 FY | 11.21 Million USD | 52.54% |
| 2019 Q1 | 2.47 Million USD | 8.61% |
| 2019 Q2 | 2.6 Million USD | 5.41% |
| 2018 Q2 | 1.64 Million USD | 1.41% |
| 2018 FY | 7.35 Million USD | -0.36% |
| 2018 Q4 | 2.27 Million USD | 25.98% |
| 2018 Q1 | 1.62 Million USD | -3.34% |
| 2018 Q3 | 1.8 Million USD | 9.76% |
| 2017 Q3 | 1.71 Million USD | -13.1% |
| 2017 FY | 7.37 Million USD | 28.35% |
| 2017 Q1 | 2 Million USD | 22.75% |
| 2017 Q2 | 1.97 Million USD | -1.55% |
| 2017 Q4 | 1.67 Million USD | -2.2% |
| 2016 Q3 | 1.61 Million USD | 46.42% |
| 2016 Q2 | 1.1 Million USD | -20.82% |
| 2016 Q1 | 1.39 Million USD | -7.77% |
| 2016 FY | 5.74 Million USD | 25.15% |
| 2016 Q4 | 1.63 Million USD | 1.16% |
| 2015 FY | 4.59 Million USD | 27.46% |
| 2015 Q4 | 1.51 Million USD | 21.28% |
| 2015 Q3 | 1.24 Million USD | 50.95% |
| 2015 Q2 | 825.74 Thousand USD | -18.28% |
| 2015 Q1 | 1.01 Million USD | 5.27% |
| 2014 Q3 | 633.2 Thousand USD | -46.74% |
| 2014 Q1 | 822.53 Thousand USD | -30.08% |
| 2014 Q4 | 959.84 Thousand USD | 51.58% |
| 2014 FY | 3.6 Million USD | -8.3% |
| 2014 Q2 | 1.18 Million USD | 44.54% |
| 2013 Q4 | 1.17 Million USD | 26.84% |
| 2013 FY | 3.93 Million USD | -22.29% |
| 2013 Q1 | 1.26 Million USD | -32.13% |
| 2013 Q2 | 562.48 Thousand USD | -55.51% |
| 2013 Q3 | 927.45 Thousand USD | 64.88% |
| 2012 Q4 | 1.86 Million USD | 64.57% |
| 2012 Q2 | 1.08 Million USD | 10.59% |
| 2012 Q1 | 979.99 Thousand USD | -15.82% |
| 2012 FY | 5.05 Million USD | 32.48% |
| 2012 Q3 | 1.13 Million USD | 4.44% |
| 2011 FY | 3.81 Million USD | 43.03% |
| 2011 Q3 | 1.15 Million USD | 59.76% |
| 2011 Q4 | 1.16 Million USD | 0.8% |
| 2011 Q2 | 722.88 Thousand USD | 0.0% |
| 2010 FY | 2.66 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -98.648% |
| BrainsWay Ltd. | 31.78 Million USD | 24.634% |
| Cerus Corporation | 156.36 Million USD | 84.68% |
| Envoy Medical, Inc. | 316 Thousand USD | -7480.696% |
| electroCore, Inc. | 16.03 Million USD | -49.439% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -3619.72% |
| IceCure Medical Ltd | 3.22 Million USD | -641.871% |
| Inogen, Inc. | 315.66 Million USD | 92.411% |
| OrthoPediatrics Corp. | 148.73 Million USD | 83.894% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -886.614% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -6463.032% |
| MaxCyte, Inc. | 41.28 Million USD | 41.981% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -1126.926% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -21530.187% |
| Orthofix Medical Inc. | 746.64 Million USD | 96.792% |
| PAVmed Inc | 2.45 Million USD | -876.958% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -6.377% |
| RxSight, Inc. | 89.07 Million USD | 73.108% |
| Sight Sciences, Inc. | 81.05 Million USD | 70.446% |
| SI-BONE, Inc. | 138.88 Million USD | 82.752% |
| TELA Bio, Inc. | 58.45 Million USD | 59.018% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 87.198% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -73.574% |
| Acutus Medical, Inc. | 7.16 Million USD | -234.38% |
| Talis Biomedical Corporation | 412 Thousand USD | -5714.32% |
| Spectral AI, Inc. | 18.05 Million USD | -32.671% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -141.848% |
| CVRx, Inc. | 39.29 Million USD | 39.038% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -2372.887% |
| Bioventus Inc. | 512.34 Million USD | 95.324% |
| Venus Concept Inc. | 76.35 Million USD | 68.626% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -29.41% |
| LivaNova PLC | 1.15 Billion USD | 97.923% |
| 908 Devices Inc. | 50.22 Million USD | 52.308% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 95.033% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -30992.622% |
| NeuroPace, Inc. | 65.42 Million USD | 63.383% |
| LENSAR, Inc. | 42.16 Million USD | 43.186% |
| Apyx Medical Corporation | 52.34 Million USD | 54.24% |
| Cutera, Inc. | 212.36 Million USD | 88.72% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 28.188% |
| BioSig Technologies, Inc. | 18 Thousand USD | -132983.333% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 85.627% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 98.446% |
| Axonics, Inc. | 366.37 Million USD | 93.462% |
| Outset Medical, Inc. | 130.37 Million USD | 81.626% |
| IRIDEX Corporation | 51.86 Million USD | 53.816% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 82.411% |
| IRadimed Corporation | 65.56 Million USD | 63.462% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -1936.99% |
| INVO Bioscience, Inc. | 3.02 Million USD | -693.061% |
| Telesis Bio, Inc. | 27.5 Million USD | 12.919% |
| Viemed Healthcare, Inc. | 183 Million USD | 86.91% |
| Varex Imaging Corporation | 811 Million USD | 97.046% |
| Quipt Home Medical Corp. | 221.74 Million USD | 89.197% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 65.118% |
| Dynatronics Corporation | 32.53 Million USD | 26.369% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -176.043% |
| Semler Scientific, Inc. | 68.18 Million USD | 64.867% |
| InMode Ltd. | 492.04 Million USD | 95.132% |
| Bruker Corporation | 2.96 Billion USD | 99.192% |
| Cytosorbents Corporation | 36.34 Million USD | 34.098% |
| DexCom, Inc. | 3.62 Billion USD | 99.339% |
| Align Technology, Inc. | 3.86 Billion USD | 99.38% |
| Viveve Medical, Inc. | 6.42 Million USD | -272.782% |
| ZimVie Inc. | 457.43 Million USD | 94.763% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 87.589% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -21530.187% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 96.796% |
| Profound Medical Corp. | 7.33 Million USD | -226.762% |
| Insulet Corporation | 1.69 Billion USD | 98.588% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 81.0% |
| iCAD, Inc. | 17.31 Million USD | -38.324% |
| Nuwellis, Inc. | 8.86 Million USD | -170.25% |
| Biotricity, Inc. | 12.06 Million USD | -98.577% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 95.138% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -286.06% |
| PAVmed Inc. | 2.45 Million USD | -876.958% |
| BIOLASE, Inc. | 49.16 Million USD | 51.275% |
| Beyond Air, Inc. | 1.15 Million USD | -1966.868% |
| FONAR Corporation | 102.88 Million USD | 76.717% |
| AxoGen, Inc. | 159.01 Million USD | 84.935% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 91.271% |
| Inari Medical, Inc. | 493.63 Million USD | 95.147% |
| UFP Technologies, Inc. | 400.07 Million USD | 94.012% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -128690.323% |
| Tenon Medical, Inc. | 2.92 Million USD | -718.135% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -251.657% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.251% |
| Sintx Technologies, Inc. | 2.62 Million USD | -811.877% |
| NanoVibronix, Inc. | 2.28 Million USD | -949.277% |
| Quanterix Corporation | 122.36 Million USD | 80.424% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 1.844% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 88.054% |
| TransMedics Group, Inc. | 241.62 Million USD | 90.086% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -72.91% |
| NeuroMetrix, Inc. | 5.9 Million USD | -305.919% |
| Hyperfine, Inc. | 11.03 Million USD | -117.141% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 85.495% |
| Biomerica, Inc. | 5.41 Million USD | -342.382% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 52.622% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 86.476% |